← Back to Patent Explorer
US4607041A Expired / Lapsed US ⏱️ 0.0 years remaining

Antihypertensive 2-phenyl Hantzsch dihydropyridines

Assignee: Fisons Ltd
•
Filing: 1984-04-17
•
Granted: 1986-08-19
•
Expires: 2004-04-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are described compounds of formula I, ##STR1## in which R 1 represents benzofurazanyl, pyridyl or phenyl, the pyridyl or phenyl being substituted by one or more of the groups halogen, nitro, --CN, --OR 9 , --S(O) p R 9 , or alkyl C1 to 6 optionally substituted by halogen, p is 0, 1 or 2, R 2 and R 3 , which may be the same or different, each represent hydrogen; alkyl C1 to 6 optionally substituted by one or more of the groups halogen, cyano, --XR 4 , --NR 5 R 6 or phenyl; cycloalkyl C3 to 8 optionally substituted by alkyl C1 to 6; a 4, 5 or 6 membered oxygen or nitrogen containing heterocyclic ring which is optionally substituted by alkyl C1 to 6 the alkyl in turn optionally being substituted by one or more phenyl groups; R 5 and R 6 , which may be the same or different, each represent alkyl C1 to 6 optionally substituted by phenyl, Y and Z together form a bond, and additionally, when R 8 is an electron withdrawing group Y may be hydrogen and Z may be hydroxy, one of R 7 and R 8 represents alkyl C1 to 6 and the other represents phenyl, or R 7 and R 8 may be the same or different and each represents phenyl optionally substituted by one or more of alkyl C1 to 6, halogen, alkoxy C1 to 6 or nitro; amino; alkyl C1 to 6 substituted by halogen; --CN; --CH 2 OH; --CHO or --CH(OR 9 ) 2 , X is O or S, R 4 is alkyl C1 to 6 or phenyl, R 9 is alkyl C1 to 6, with certain provisons. There are also described processes for making the compounds, and their formulation and use as pharmaceuticals for treatment of hypertension, angina, or congestive heart failure.

Inventors

  • 👤 Andrew J. G. Baxter
  • 👤 John Dixon
  • 👤 Thomas McInally
  • 👤 Alan C. Tinker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 02:14
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; C07C; C07C17/00; C07C17/093; C07C205/00; C07C205/49; C07C205/56; C07C45/00; C07C47/00; C07C47/52; C07C47/55; C07D205/00; C07D205/02; C07D205/04; C07D211/00; C07D211/04; C07D211/68; C07D211/72; C07D211/78; C07D211/80; C07D211/84; C07D211/90; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08; C07D305/00; C07D305/02; C07D305/04; C07D305/08; C07D309/00; C07D309/02; C07D309/08; C07D309/10; C07D309/12; C07D401/00; C07D401/02; C07D401/04; C07D405/00; C07D405/02; C07D405/04; C07D413/00; C07D413/02; C07D413/04

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 267 words
A compound of formula ##STR4## in which R 1 represents benzofurazanyl or phenyl, the phenyl being substituted by one or more of the groups halogen, nitro, --CN, --OR 9 , --S(O) p R 9 , or alkyl C 1 to C 6 optionally substituted by halogen, p is 0, 1 or 2, R.sub. 2 and R 3 , which may be the same or different, each represent hydrogen; alkyl C 1 to C 6 optionally substituted by one or more of the groups halogen, cyano, --XR 4 , --NR 5 R 6 or phenyl; cycloalkyl C 3 to C 8 optionally substituted by alkyl C 1 to C 6 ; an oxetanyl, azetidinyl, piperidinyl or tetrahydropyranyl ring which is optionally substituted by alkyl C 1 to C 6 , the alkyl in turn optionally being substituted by one or more phenyl groups; R 5 and R 6 , which may be the same or different, each represent alkyl C 1 to C 6 optionally substituted by phenyl, Y and Z together form a bond, one of R 7 and R 8 represents alkyl C 1 to C 6 and the other represents phenyl, X is O or S, R 4 is alkyl C 1 to C 6 or phenyl, and R 9 is alkyl C 1 to C 6 , provided that when R 7 is alkyl C 1 to C 6 , R 1 represents 3-nitrophenyl and R 2 and R 3 are both ethyl, then R 8 does not represent phenyl, and pharmaceutically acceptable acid addition salts of those compounds containing a basic nitrogen atom.
Claim 2
Dependent Claim 267 words
A compound of formula ##STR4## in which R 1 represents benzofurazanyl or phenyl, the phenyl being substituted by one or more of the groups halogen, nitro, --CN, --OR 9 , --S(O) p R 9 , or alkyl C 1 to C 6 optionally substituted by halogen, p is 0, 1 or 2, R.sub. 2 and R 3 , which may be the same or different, each represent hydrogen; alkyl C 1 to C 6 optionally substituted by one or more of the groups halogen, cyano, --XR 4 , --NR 5 R 6 or phenyl; cycloalkyl C 3 to C 8 optionally substituted by alkyl C 1 to C 6 ; an oxetanyl, azetidinyl, piperidinyl or tetrahydropyranyl ring which is optionally substituted by alkyl C 1 to C 6 , the alkyl in turn optionally being substituted by one or more phenyl groups; R 5 and R 6 , which may be the same or different, each represent alkyl C 1 to C 6 optionally substituted by phenyl, Y and Z together form a bond, one of R 7 and R 8 represents alkyl C 1 to C 6 and the other represents phenyl, X is O or S, R 4 is alkyl C 1 to C 6 or phenyl, and R 9 is alkyl C 1 to C 6 , provided that when R 7 is alkyl C 1 to C 6 , R 1 represents 3-nitrophenyl and R 2 and R 3 are both ethyl, then R 8 does not represent phenyl, and pharmaceutically acceptable acid addition salts of those compounds containing a basic nitrogen atom.
Claim 3
Dependent Claim 37 words
A compound according to claim 1, in which R 1 is 4-benzofurazanyl, or phenyl substituted by nitro, chloro or --CF 3 , and R 2 and R 3 are each alkyl C 1 to C 3 .
Claim 4
Dependent Claim 25 words
A compound according to claim 1 and selected from Diethyl 1,4-dihydro-2-methyl-6-phenyl-4-(2-(trifluoromethyl)phenyl)-3,5-pyridinedicarboxylate, 5-Methyl 3-(1-methylethyl) 4-(4-benzofurazanyl)1,4-dihydro-2-methyl-6-phenyl-3, 5-pyridinedicarboxylate, 5-methyl 3-(1-methylethyl) 1,4-dihydro-2-methyl-6phenyl-4-(2-(trifluoromethyl)phenyl)-3,5-pyridinedicarboxylate, 3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2-methyl-6-phenyl-3,5-pyridinedicarboxylate, and 5-Methyl 3-(1-methylethyl) 1,4-dihydro-2-methyl-4-(3-nitrophenyl)-6-phenyl-3,5-pyridinedicarboxylate.
Claim 5
Dependent Claim 27 words
A compound according to claim 1, in which R 1 is phenyl carrying at least two substituents selected from chloro, fluoro, --CF 3 , methyl and nitro.
Claim 6
Dependent Claim 12 words
A compound according to claim 1, in which R 1 is benzofurazanyl.
Claim 7
Dependent Claim 42 words
A pharmaceutical formulation containing an amount of a compound according to claim 1 effective to treat renovascular, malignant or essential hypertension, pulmonary hypertension, vasospastic angina, chronic stable angina or congestive heart failure, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier.
Claim 8
Dependent Claim 42 words
A method of treatment of renovascular, malignant or essential hypertension, pulmonary hypertension, vasospastic angina, chronic stable angina or congestive heart failure, which comprises administering an effective amount of a compound according to claim 1 to a patient suffering from such a condition.

References Cited (Backward Citations)

DE2117573A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-08-18 1990-02-17 1990-08-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-08-18 1994-02-17 1994-08-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-08-18 1998-02-17 1998-08-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag